If adequate psychometric properties are found for the GAD-Q-IV (Newman et al., 2002) in postpartum mothers (i.e., in the present and future studies), health-care professionals could use the GAD-Q-IV as a diagnostic screening instrument to detect the likely presence of GAD in postpartum mothers and recommend treatment(s) to prevent the chronic and detrimental effects of GAD in this population. The gene discussed is GAD1; the disease is generalized anxiety disorder.